Sort
30,917 grants matching “tumor microenvironment”
Glioblastoma-secreted GABA contributes to the immunosuppressive environment
$432,250Daniel Kaufman · University Of California Los Angeles · R21 · FY2024 · NS
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$432,171Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2021 · CA
Protein Kinase Cz targets in Intestinal Cancer Stem Cells
$432,152Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Targeting Nucleotide Excision Repair Deficiency to Improve Bladder Sparing Treatment for Muscle Invasive Bladder Cancer
$432,128Kent W Mouw · Dana-Farber Cancer Inst · R01 · FY2022 · CA
HIV persistence and treatment response in Kaposi sarcoma
$432,098Edus Houston Warren · Fred Hutchinson Cancer Center · R21 · FY2025 · CA
Regulation of Urinary Bladder Carcinogenesis and Progression by SPARC
$432,063Neveen Said · Wake Forest University Health Sciences · R01 · FY2020 · CA
Contribution of osteocytes to the musculoskeletal effects of Multiple Myeloma
$432,059Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R01 · FY2024 · CA
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
$432,034Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2023 · CA
The regulation and targeting of cell survival pathways in cancer
$431,999Joshua Lyon Andersen · Brigham Young University · R15 · FY2016 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,993Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2025 · CA
The role of P16Ink4a in adult skeletal muscle stem cells
$431,984Brian Feeley · University Of California, San Francisco · R01 · FY2024 · AR
The role of P16Ink4a in adult skeletal muscle stem cells
$431,984Brian Feeley · University Of California, San Francisco · R01 · FY2025 · AR
Nicotinamide N-Methyltransferase (NNMT) as a master regulator of cancer stroma
$431,980Ernst Lengyel · University Of Chicago · R01 · FY2017 · CA
Monitoring Listeria in vivo using 18FDG and PET scan
$431,970Claudia Gravekamp · Albert Einstein College Of Medicine · R21 · FY2024 · CA
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma
$431,968Eveline Barbieri · Baylor College Of Medicine · R01 · FY2024 · CA
Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer
$431,920Heather M O'Hagan · Indiana University Indianapolis · R01 · FY2024 · CA
Systematic characterization of cancer variants using single-cell functional genomics
$431,914Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2023 · CA
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
$431,912Anh D Le · University Of Pennsylvania · R01 · FY2024 · DE
Targeting immune suppressive microenvironment in ATC
$431,902James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Targeting immune suppressive microenvironment in ATC
$431,902James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Three-dimensional organoid models to study breast cancer progression
$431,871Shilpa Sant · University Of Pittsburgh At Pittsburgh · R37 · FY2019 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$431,818Bruce K Walcheck · University Of Minnesota · R01 · FY2023 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$431,814Bruce K Walcheck · University Of Minnesota · R01 · FY2022 · CA
Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma
$431,810Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2019 · CA
NGTC - UCL
$431,742Martin Pule · University College London · OT2 · FY2023 · CA